Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury

International Journal of Cardiology

Volumn 134, Issue 3, 2009, Pages 384-392

  Shan, Xiaohong ^a,b   Xu, Xuan ^a   Cao, Bin ^a   Wang, Yongmei ^a   Guo, Lin ^a   Zhu, Quan ^a   Li, Jing ^a   Que, Linli ^a   Chen, Qi ^a   Ha, Tuanzhu ^c   Li, Chuanfu ^c   Li, Yuehua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c East Tennessee State University   (United States)

Author keywords

Cardiomyocyte; Cardioprotection; Erythropoietin; Ischemia reperfusion; Transcription factor GATA 4

Indexed keywords

CASPASE 3; ERYTHROPOIETIN; PLASMID DNA; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA TRANSFECTION; DRUG MECHANISM; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; ERYTHROPOIETIN; GATA4 TRANSCRIPTION FACTOR; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL REPERFUSION INJURY;

EID: 67349213293     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.043     Document Type: Article

References (38)

1. Grasso G., Sfacteria A., Erbayraktar S., et al. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine 4 (2006) 310-318
2. Parsa C.J., Kim J., Riel R.U., Pascal L.S., Thompson R.B., and Petrofski J.A. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279 (2004) 20655-20662
3. Asaumi Y., Kagaya Y., Takeda M., et al. Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation 115 (2007) 2022-2032
4. Calvillo L., Latini R., Kajstura J., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100 (2003) 4802-4806
5. Tada H., Kagaya Y., Takeda M., et al. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 71 (2006) 408-410
6. Ramond A., Sartorius E., Mousseau M., Ribuot C., and Joyeux-Faure M. Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts. Exp Biol Med (Maywood) 233 (2008) 76-83
7. Cai Z., and Semenza G.L. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109 (2004) 2050-2053
8. Hirata A., Minamino T., Asanuma H., et al. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther 19 (2005) 33-40
9. Parsa C.J., Kim J., Riel R.U., et al. Cardioprotective effects of erythropoietin in the reperfused ischemic heart. J Biol Chem 279 (2004) 20655-20662
10. Ribeil J.A., Zermati Y., Vandekerckhove J., et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 445 (2007) 102-105
11. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6, Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275 (2000) 38949-38952
12. Patient R.K., and McGhee J.D. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 12 (2002) 416-422
13. Kim Y., Ma A.G., Kitta K., et al. Anthacycline-induced downregulation of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63 (2003) 368-377
14. Kobayashi S., Lackey T., Huang Y., et al. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 206 (2006) 800-802
15. Suzuki Y.J., Nagase H., Day R.M., and Das D.K. GATA-4 regulation of myocardial survival in the preconditioned heart. J Mol Cell Cardiol 37 (2004) 195-203
16. Aries A., Paradis P., Lefebvre C., Schwartz R.J., and Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci U S A 101 (2004) 6975-6980
17. Li Y., Ha T., Gao X., et al. NF-kB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 287 (2004) 1712-1720
18. Li C., Kao R.L., Ha T., Kelley J., Browder I.W., and Williams D.L. Early activation of IKKh during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 280 (2001) H1264-1271
19. Li C., Ha T., Kelley J., et al. Modulating toll-like receptor mediated signaling by (1 -->Ä 3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61 (2004) 538-547
20. De Windt L.J., Lim H.W., Taigen T., et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res 86 (2000) 255-263
21. 2 adrenergic receptor cDNA. J Clin Invest 101 (1998) 337-343
22. Tramontano A.F., Muniyappa R., Black A.D., et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308 (2003) 990-994
23. Kitta K., Clement S.A., Remeika J., Blumberg J.B., and Suzuki Y.J. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in HL-1 atrial-muscle cell line. Biochem J 359 (2001) 375-380
24. McCully J.D., Wakiyama H., Hsieh Y.J., Jones M., and Levitsky S. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 286 (2004) 1923-1935
25. Chandrasekar B., Mummidi S., Claycomb W.C., Mestril R., and Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem 280 (2005) 4553-4567
26. Nishiya1 D., Omura1 T., Shimada K., Matsumoto R., and Kusuyama T. Effects of erythropoietin on cardiac remodeling after myocardial infarction. J Pharmacol Sci 101 (2006) 31-39
27. Patient R.K., and McGhee J.D. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 12 (2002) 416-422
28. Arai M., Tomaru K., Takizawa T., et al. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J Mol Cell Cardiol 30 (1998) 243-254
29. Jay P.Y., Bielinska M., Erlich J.M., et al. Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects. Dev Biol 301 (2007) 602-614
30. Heikinheimo M., Ermolaeva M., Bielinska M., et al. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138 (1997) 3505-3514
31. Li L., Takemura G., Li Y., et al. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113 (2006) 535-543
32. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., and Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276 (2001) 30245-30253
33. Tong H., Imahashi K., Steenbergen C., and Murphy E. Phosphorylation of glycogen synthase kinase-3 during preconditioning though a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90 (2002) 377-379
34. Naito A.T., Tominaga A., Oyamada M., et al. Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002. Exp Cell Res 291 (2003) 56-69
35. Condorelli G., Drusco A., Stassi G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 12333-12338
36. Morisco C., Seta K., Hardt S.E., Lee Y., Vatner S.F., and Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 276 (2001) 28586-28597
37. Grillot D.A., Gonzalez-Garcia M., Ekhterae D., et al. Genomic organization, promoter analysis and chromosome localization of the mouse bcl-x gene. J Immunol. 158 (1997) 4750-4757
38. Kitta K., Day R.M., Kim Y., Torregroza I., Evans T., and Suzuki Y.J. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278 (2003) 4705-4712